PURE — PURE BIOSCIENCE, INC.

OTC · Materials · Chemicals · CIK 1006028 ·
Last close
$0.07
Market Cap
$9.10M
52W High
$0.10
52W Low
$0.04
ADV30
24,398
Next earnings
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company's technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Apr 2026 506,000 269,000 -518,000 -624,000 1,558,000 983,000 7,397,000
Jan 2026 444,000 238,000 -683,000 -785,000 788,000 198,000 7,061,000
Oct 2025 708,000 450,000 -379,000 -464,000 1,186,000 434,000 6,732,000
Apr 2025 491,000 283,000 -584,000 -580,000 1,057,000 540,000 5,871,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,836,000
Investing CF
Financing CF
$2,823,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.03
As of
2026-06-21

Balance + Analyst (yfinance extras)

Retained Earnings
$-140,867,000
Inventory
$232,000
Receivables
$242,000
ST Investments
EBIT TTM
$-2,074,000
Pretax Income TTM
$-2,453,000
Interest Exp TTM
$379,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,422,000
EBITDA
$-1,914,000
Free Cash Flow
$-1,394,250
Enterprise Value
$13,412,567
Total Cash
$983,000
Total Debt
$6,497,000
Shares Out
130,017,569
Trailing EPS
$-0.02
Book Value
$-0.04
ROE
ROA
-91.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Jul 2024 1,963,000 -3,131,000 -3,350,000 818,000 3,682,000 -2,531,000
Jul 2023 1,877,000 -3,628,000 -3,961,000 1,825,000 1,553,000 -3,278,000
Jul 2022 1,853,000 -3,370,000 -3,491,000 4,484,000 575,000 -2,418,000
Jul 2021 3,927,000 -2,311,000 -2,319,000 4,303,000 970,000 -1,167,000

Peers — same industry

TickerNameMarket CapLastDaily %
MTEX MANNATECH INC $9.07M $4.70
SUIC SUIC Worldwide Holdings Ltd. $9.69M $0.85
BNET BION ENVIRONMENTAL TECHNOLOGIES INC $9.76M $0.17
BNKK BONK, INC. $9.84M $1.23
YCBD cbdMD, Inc. $8.27M $0.79

News headlines (Yahoo Finance, 1h cache)

PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
2026-06-15 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.